each hematological malignancy was as follows: ALL 6.15%, AML 5.38%, NHL 5.38%, CML 4.62%, CLL 2.31% and HD 0.77%. Conclusion: TLS is not an uncommon complication of hematological malignancies
genes, including BCL2 have been observed in various cancers including melanoma, breast, prostate, and CLL, as well as in resistance to cancer treatment. In many studies, to eliminate cancer cells
major types namely Acute Lymphocytic Leukemia (ALL), Acute Myelogenous Leukemia (AML), Chronic Lymphocytic Leukemia (CLL) and Chronic Myelogenous Leukemia (CML). ALL is a cancer of the white blood cells that
year-old Caucasian male patient with chronic lymphocytic leukemia/small cell lymphoma (CLL/SLL) related secondary ITP who had been maintained for nearly a decade on romiplostim after failing
year old Moroccan man was diagnosed with chronic lymphocytic leukaemia (CLL) in 2007. He was also known to have hypogammaglobulinaemia. He had obtained a good partial response after completing twelve
suitable prognostic marker in the identification of metastatic growth chronic lymphocytic leukemia (CLL) and acute myeloblastic leukemia (AML) in Turk populations
reference methodologies including flow cytometry and PCR. Lastly, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) is the most common leukemia diagnosed among adults in western countries and is…
meningiomas. This case presents the second documented collision of a systemic chronic lymphocytic leukemia (CLL) to a glioblastoma multiforme (GBM). Lymphomas tend to coalesce in perivascular locations, and the…
years of therapy. Most however received Prednisolone as adjunctive treatment for their cancers namely: CLL, CML, ALL, AML and Hodgkin’s Lymphoma. The low rate of heart disease
cell CLL/lymphoma 6 (BCL6), a transcriptional repressor, is involved in the development and progression of breast cancers with uncertain mechanism. It was found that the expression of BCL6 positively
blood, plasma or serum. Circulating cf-DNA isolated from chronic lymphocytic leukemia (CLL) patient blood and plasma samples by DEP were PCR amplified to identify the VHL genotype and then
group indicating B19 may be naturally Oncolytic further prolonged remission in a child with CLL and another with CML ratified our clinical observations. Now several reports on pediatric B19 infections
naturally Oncolytic (Kishore J; 2014) further prolonged remission in a child with CLL and another with CML (co-author Kishore J; 2015) ratified our clinical observations. Now several reports
initial discovery as a relatively specific surface antigen on B cell chronic lymphocytic leukemia (CLL) in 2008. The list of cancer types with ROR1 expression keeps growing, comprising, among others
cells is directed towards CD19 to treat Bcell malignancies, including chronic lymphocytic leukemia (CLL), B-cell acute lymphoblastic leukemia (ALL), and non-Hodgkin lymphomas
chemotherapy-induced apoptosis. It has potential to be used in chronic lymphocytic leukaemia (CLL), Melanoma and small cell and non-small cell lung cancer. âÂ
responses in patients with advanced cancer (acute lymphocytic leukemia patients and chronic lymphocytic leukemia (CLL) patients). Recently, we demonstrated that adoptive transfer of tumor-specific Th9 cells strongly…
Twelve formalin fixed and paraffin embedded lung tumors and twelve native Chronic Lymphocytic Leukemia (CLL) samples, respectively, were analyzed. Samples were sequenced on the MiSeq sequencer platform. The results…
smears of 19 AML patients and in WBC concentrated peripheral blood smears of 19 CLL patients. In order to evaluate the clinical implication of that method, our purpose
intensity conditioning (RIC) allogeneic stem cell transplantation (ASCT) in patients with chronic lymphocytic leukemia (CLL) we performed a retrospective review of patients referred for transplant consultation at our…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.